Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""COMBINED modality therapy"" wg kryterium: Temat


Tytuł :
The Role of Neoadjuvant Versus Adjuvant Therapy for Duodenal Adenocarcinoma: A National Cancer Database Propensity Score Matched Analysis.
Autorzy :
Linden K; Department of Surgery, Cooper University Hospital, Camden, NJ, USA.
Melillo A; Department of Surgery, Cooper University Hospital, Camden, NJ, USA.
Gaughan J; 363994Cooper Medical School of Rowan University, Camden, NJ, USA.
Obinero C; 363994Cooper Medical School of Rowan University, Camden, NJ, USA.
Kellish A; 363994Cooper Medical School of Rowan University, Camden, NJ, USA.
Wozniak MR; 363994Cooper Medical School of Rowan University, Camden, NJ, USA.
Patel RM; 363994Cooper Medical School of Rowan University, Camden, NJ, USA.
Pandya V; 363994Cooper Medical School of Rowan University, Camden, NJ, USA.
Atabek U; Department of Surgery, Cooper University Hospital, Camden, NJ, USA.
Spitz F; Department of Surgery, Cooper University Hospital, Camden, NJ, USA.
Hong YK; Department of Surgery, Cooper University Hospital, Camden, NJ, USA.
Pokaż więcej
Źródło :
The American surgeon [Am Surg] 2021 Jul; Vol. 87 (7), pp. 1066-1073. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Combined Modality Therapy*
Adenocarcinoma/*mortality
Adenocarcinoma/*therapy
Duodenal Neoplasms/*mortality
Duodenal Neoplasms/*therapy
Aged ; Databases, Factual ; Female ; Humans ; Male ; Middle Aged ; Propensity Score ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer.
Autorzy :
Portuondo JI; Center for Innovations in Quality, Effectiveness, and Safety, Michael E DeBakey VA Medical Center, Houston, Texas, USA.; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
Tran Cao HS; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
da Costa WL; Department of Medicine, Epidemiology, and Population Sciences, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Sada YH; Center for Innovations in Quality, Effectiveness, and Safety, Michael E DeBakey VA Medical Center, Houston, Texas, USA.; Division of Medical Oncology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Harris AHS; Veterans Affairs Health Services Research and Development Center for Innovation to Implementation, Palo Alto Veterans Affairs Health Care System, Menlo Park, California, USA.; Department of Surgery, Stanford University, Palo Alto, California, USA.
Massarweh NN; Center for Innovations in Quality, Effectiveness, and Safety, Michael E DeBakey VA Medical Center, Houston, Texas, USA.; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 May; Vol. 123 (8), pp. 1724-1735. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article
MeSH Terms :
Combined Modality Therapy*
Hospitalization*
Practice Patterns, Physicians'*
Stomach Neoplasms/*therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Gastrectomy ; Humans ; Male ; Middle Aged ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Survival Rate ; United States ; Young Adult
Czasopismo naukowe
Tytuł :
Cytokine release syndrome and complete remission of extra medullary acute lymphoblastic leukemia of the breast with CAR-T and radiation therapy.
Autorzy :
Ragoonanan D; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.
Tambaro FP; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.; CARTOX Program, University of Texas MD Anderson Cancer Center, Houston, Texas.; UOC SIT-TMO AORN Santobono-Pausilipon-Napoli, Napoli, Italy.
Khazal SJ; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.; CARTOX Program, University of Texas MD Anderson Cancer Center, Houston, Texas.
Tewari P; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.; CARTOX Program, University of Texas MD Anderson Cancer Center, Houston, Texas.
Petropoulos D; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.; CARTOX Program, University of Texas MD Anderson Cancer Center, Houston, Texas.
Champlin R; CARTOX Program, University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, Texas.
Mahadeo KM; Department of Pediatrics, Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.; CARTOX Program, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2021 May; Vol. 68 (5), pp. e28839. Date of Electronic Publication: 2020 Nov 30.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Breast Neoplasms/*therapy
Combined Modality Therapy/*methods
Cytokine Release Syndrome/*etiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Combined Modality Therapy/adverse effects ; Fatal Outcome ; Female ; Humans ; Immunotherapy, Adoptive/adverse effects ; Immunotherapy, Adoptive/methods ; Radiotherapy/adverse effects ; Radiotherapy/methods ; Receptors, Chimeric Antigen ; Remission Induction ; Young Adult
Raport
Tytuł :
The combined therapy of fecal microbiota transplantation and laxatives for functional constipation in adults: A systematic review and meta-analysis of randomized controlled trials.
Autorzy :
Fang S; Zhejiang Chinese Medical University.
Wu S; Zhejiang Chinese Medical University.
Ji L; Zhejiang Chinese Medical University.
Fan Y; Zhejiang Chinese Medical University.
Wang X; Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Yang K; Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Apr 09; Vol. 100 (14), pp. e25390.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Combined Modality Therapy/*methods
Constipation/*physiopathology
Constipation/*therapy
Fecal Microbiota Transplantation/*methods
Laxatives/*therapeutic use
Adult ; Aged ; Case-Control Studies ; China/epidemiology ; Combined Modality Therapy/adverse effects ; Constipation/psychology ; Data Management ; Fecal Microbiota Transplantation/adverse effects ; Female ; Humans ; Laxatives/adverse effects ; Male ; Middle Aged ; Quality of Life ; Randomized Controlled Trials as Topic ; Safety ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Lower Genital Tract Melanomas: Staging, Predictors of Outcome, and New Therapeutic Options.
Autorzy :
Egger EK; Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany; .
Stope MB; Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany.
Recker F; Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany.
Konsgen D; Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany.
Landsberg J; Department of Dermatology and Allergy, University Hospital Bonn, Bonn, Germany.
Frohlich A; Department of Dermatology and Allergy, University Hospital Bonn, Bonn, Germany.
Abramian A; Department of Senology, University Hospital Bonn, Bonn, Germany.
Mustea A; Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Feb; Vol. 41 (2), pp. 999-1004.
Typ publikacji :
Journal Article
MeSH Terms :
Combined Modality Therapy/*methods
Melanoma/*therapy
Vaginal Neoplasms/*therapy
Vulvar Neoplasms/*therapy
Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/therapeutic use ; Combined Modality Therapy/mortality ; Female ; Gynecologic Surgical Procedures ; Humans ; Immunotherapy ; Kaplan-Meier Estimate ; Margins of Excision ; Melanoma/mortality ; Melanoma/pathology ; Middle Aged ; Neoplasm Staging ; Oncolytic Viruses/physiology ; Radiotherapy ; Retrospective Studies ; Treatment Outcome ; Vaginal Neoplasms/mortality ; Vaginal Neoplasms/pathology ; Vulvar Neoplasms/mortality ; Vulvar Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Trimodal therapy in muscle invasive bladder cancer management.
Autorzy :
Polo-Alonso E; Department of Urology, Instituto Valenciano de Oncologia (IVO), Valencia, Spain.
Kuk C; Division of Urology, Departments of Surgical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.; Division of Urology, Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada.
Guruli G; Division of Urology, Virginia Commonwealth University, Richmond, VA, USA.
Paul AK; Division of Hematology, Oncology and Palliative Care Unit, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Thalmann G; Division of Hematology, Oncology and Palliative Care Unit, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Kamat A; Department of Urology, Anderson Cancer Center, Houston, TX, USA.
Solsona E; Department of Urology, Instituto Valenciano de Oncologia (IVO), Valencia, Spain.
Thalmann G; Department of Urology, University Hospital of Bern, Bern, Switzerland.
Urdaneta AI; Division of Hematology, Oncology and Palliative Care Unit, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Zlotta AR; Division of Urology, Departments of Surgical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.; Division of Urology, Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada.
Mir MC; Department of Urology, Instituto Valenciano de Oncologia (IVO), Valencia, Spain - .
Pokaż więcej
Źródło :
Minerva urologica e nefrologica = The Italian journal of urology and nephrology [Minerva Urol Nefrol] 2020 Dec; Vol. 72 (6), pp. 650-662.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Combined Modality Therapy*
Neoplasm Invasiveness*
Urinary Bladder Neoplasms*/therapy
Chemotherapy, Adjuvant ; Cystectomy ; Female ; Humans ; Middle Aged ; Muscles ; Neoadjuvant Therapy ; Organ Sparing Treatments ; Patient Selection ; Quality of Life ; Salvage Therapy ; Survival Rate
Czasopismo naukowe
Tytuł :
Prognostic factors in patients with oligometastatic breast cancer - A systematic review.
Autorzy :
van Ommen-Nijhof A; Department of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, PO Box 90203, 1006 BE Amsterdam, the Netherlands. Electronic address: .
Steenbruggen TG; Department of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, PO Box 90203, 1006 BE Amsterdam, the Netherlands.
Schats W; Department of Scientific Information Service, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, PO Box 90203, 1006 BE Amsterdam, the Netherlands.
Wiersma T; Department of Radiation Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, PO Box 90203, 1006 BE Amsterdam, the Netherlands.
Horlings HM; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, PO Box 90203, 1006 BE Amsterdam, the Netherlands.
Mann R; Department of Radiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, PO Box 90203, 1006 BE Amsterdam, the Netherlands.
Koppert L; Department of Surgical Oncology, Erasmus MC Cancer Institute, PO Box 2060, 3000 CB Rotterdam, the Netherlands.
van Werkhoven E; Department of Biostatistics, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, PO Box 90203, 1006 BE Amsterdam, the Netherlands.
Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, PO Box 90203, 1006 BE Amsterdam, the Netherlands.
Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, PO Box 2060, 3000 CB Rotterdam, the Netherlands.
Pokaż więcej
Źródło :
Cancer treatment reviews [Cancer Treat Rev] 2020 Dec; Vol. 91, pp. 102114. Date of Electronic Publication: 2020 Oct 22.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Combined Modality Therapy*
Breast Neoplasms/*therapy
Breast Neoplasms/secondary ; Disease-Free Survival ; Female ; Humans ; Prognosis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Effect of Recanalization on Cerebral Edema, Long-Term Outcome, and Quality of Life in Patients with Large Hemispheric Infarctions.
Autorzy :
Wartenberg KE; Department of Neurology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany; Department of Neurology, University of Leipzig, Liebigstrasse 20, 04103 Leipzig, Germany. Electronic address: .
Henkner J; Department of Neurology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Brandt S; Department of Neuroradiology, Chemnitz Hospital, Chemnitz, Germany; Department of Neuroradiology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Zierz S; Department of Neurology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Müller TJ; Department of Neurology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2020 Dec; Vol. 29 (12), pp. 105358. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Combined Modality Therapy*
Quality of Life*
Thrombectomy*/adverse effects
Thrombectomy*/mortality
Brain Edema/*therapy
Cerebrum/*blood supply
Infarction, Middle Cerebral Artery/*therapy
Brain Edema/diagnosis ; Brain Edema/mortality ; Brain Edema/physiopathology ; Disability Evaluation ; Female ; Functional Status ; Humans ; Infarction, Middle Cerebral Artery/diagnosis ; Infarction, Middle Cerebral Artery/mortality ; Infarction, Middle Cerebral Artery/physiopathology ; Male ; Middle Aged ; Prospective Studies ; Recovery of Function ; Thrombolytic Therapy/adverse effects ; Thrombolytic Therapy/mortality ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Oncolytic virus combined with traditional treatment versus traditional treatment alone in patients with cancer: a meta-analysis.
Autorzy :
Li Y; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China.
Shen Y; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China.
Tang T; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China.
Tang Z; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China.
Song W; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China.
Yang Z; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China.
Zhang X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China.
Wang M; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China.; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China.
Bai X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China. .; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China. .; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China. .
Liang T; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310006, Zhejiang Province, China. .; Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China. .; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, China. .
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2020 Nov; Vol. 25 (11), pp. 1901-1913. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Combined Modality Therapy*/adverse effects
Oncolytic Virotherapy*/adverse effects
Neoplasms/*mortality
Neoplasms/*therapy
Anemia/etiology ; Fatigue/etiology ; Humans ; Neutropenia/etiology ; Oncolytic Viruses ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Continuous peripheral nerve blocks compared to thoracic epidurals or multimodal analgesia for midline laparotomy: a systematic review and meta-analysis.
Autorzy :
Bailey, Jonathan G.
Morgan, Catherine W.
Christie, Russell
Xue Chen Ke, Janny
Kwofie, M. Kwesi
Uppal, Vishal
Pokaż więcej
Alternatywny tytuł :
정중선 개복술을 위한 흉부 경막외 혹은 다중모드 진통과 지속 말초 신경 차단(CPNB)의 비교: 체계적 문헌검토 및 메타분석
Źródło :
Korean Journal of Anesthesiology. Oct2021, Vol. 74 Issue 5, p394-408. 15p.
Czasopismo naukowe
Tytuł :
Overcoming barriers to mental health care: multimodal trauma-focused treatment approach for unaccompanied refugee minors.
Autorzy :
van Es, Carlijn M. (AUTHOR)
Sleijpen, Marieke (AUTHOR)
Velu, Merel E. (AUTHOR)
Boelen, Paul A. (AUTHOR)
van Loon, Renate E. (AUTHOR)
Veldman, Marjan (AUTHOR)
Kusmallah, Nebil (AUTHOR)
Ekster, Paula J. C. (AUTHOR)
Mooren, Trudy (AUTHOR)
Pokaż więcej
Źródło :
Child & Adolescent Psychiatry & Mental Health. 9/30/2021, Vol. 15 Issue 1, p1-14. 14p.
Czasopismo naukowe
Tytuł :
Multimodal Treatment Combining Salvage Surgery-Assisted Chemotherapy and Checkpoints Blockade Immunotherapy Achieves Complete Remission on a Recurrent Penile Cancer Patient: A Case Report.
Autorzy :
Hu, Linjun (AUTHOR)
Shan, Xingli (AUTHOR)
Han, Dongdong (AUTHOR)
Guo, Zhaoxia (AUTHOR)
Wang, Huina (AUTHOR)
Xiao, Zejun (AUTHOR)
Pokaż więcej
Źródło :
OncoTargets & Therapy. Sep2021, Vol. 14, p4891-4896. 6p.
Czasopismo naukowe
Tytuł :
[Physical therapy in the treatment of complex regional pain syndrome].
Autorzy :
Kraft E; Muskuloskelettales Universitätszentrum München, LMU Klinikum, München, Deutschland. .; Interdisziplinäre Schmerzambulanz, Campus Großhadern, LMU Klinikum, München, Deutschland. .
Storz C; Muskuloskelettales Universitätszentrum München, LMU Klinikum, München, Deutschland.
Ranker A; Muskuloskelettales Universitätszentrum München, LMU Klinikum, München, Deutschland.; Klinik für Rehabilitationsmedizin, MHH Hannover, Hannover, Deutschland.
Pokaż więcej
Transliterated Title :
Physikalische Therapie in der Behandlung des komplexen regionalen Schmerzsyndroms.
Źródło :
Schmerz (Berlin, Germany) [Schmerz] 2021 Oct; Vol. 35 (5), pp. 363-372. Date of Electronic Publication: 2021 Sep 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Complex Regional Pain Syndromes*/therapy
Electric Stimulation Therapy*
Occupational Therapy*
Combined Modality Therapy ; Humans ; Physical Therapy Modalities
Czasopismo naukowe
Tytuł :
Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma.
Autorzy :
Hong D; Department of Interventional Radiology, The First Hospital of China Medical University, No.155 Nanjing Road, Heping District, Shenyang, 110000, Liaoning, China.
Zhou Y; Vascular Surgery and Interventional Department, Changzhou No.2 People's Hospital, 29 Xinglong Lane, Tianning District, Changzhou, 213000, Jiangsu, China.
Wan X; Department of Nuclear Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510000, China.
Su H; Department of Interventional Radiology, The First Hospital of China Medical University, No.155 Nanjing Road, Heping District, Shenyang, 110000, Liaoning, China. .
Shao H; Department of Interventional Radiology, The First Hospital of China Medical University, No.155 Nanjing Road, Heping District, Shenyang, 110000, Liaoning, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Sep 14; Vol. 21 (1), pp. 1020. Date of Electronic Publication: 2021 Sep 14.
Typ publikacji :
Journal Article
MeSH Terms :
Portal Vein*
Brachytherapy/*methods
Carcinoma, Hepatocellular/*therapy
Chemoembolization, Therapeutic/*methods
Iodine Radioisotopes/*therapeutic use
Liver Neoplasms/*therapy
Venous Thrombosis/*therapy
Brachytherapy/adverse effects ; Brachytherapy/instrumentation ; Brachytherapy/mortality ; Carcinoma, Hepatocellular/blood supply ; Carcinoma, Hepatocellular/mortality ; Chemoembolization, Therapeutic/adverse effects ; Chemoembolization, Therapeutic/mortality ; Combined Modality Therapy/adverse effects ; Combined Modality Therapy/methods ; Female ; Humans ; Iodine Radioisotopes/adverse effects ; Liver Neoplasms/blood supply ; Liver Neoplasms/mortality ; Male ; Middle Aged ; Multivariate Analysis ; Progression-Free Survival ; Retrospective Studies ; Treatment Outcome ; Ultrasonography, Interventional ; Venous Thrombosis/diagnostic imaging ; Venous Thrombosis/mortality
Czasopismo naukowe
Tytuł :
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
Autorzy :
Aman J; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Duijvelaar E; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Botros L; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Kianzad A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Schippers JR; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Smeele PJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Azhang S; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Pulmonology, Haaglanden Medisch Centrum, The Hague, Netherlands.
Bartelink IH; Department of Pharmacy, Amsterdam UMC, VUMC, Amsterdam, Netherlands.
Bayoumy AA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Pulmonology, Chest Unit, Suez Canal University, Suez, Egypt.
Bet PM; Department of Pharmacy, Amsterdam UMC, VUMC, Amsterdam, Netherlands.
Boersma W; Department of Pulmonology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands.
Bonta PI; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands.
Boomars KAT; Department of Pulmonology, Erasmus Medisch Centrum, Rotterdam, Netherlands.
Bos LDJ; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands.
van Bragt JJMH; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands.
Braunstahl GJ; Department of Pulmonology, Sint Franciscus Ziekenhuis, Rotterdam, Netherlands.
Celant LR; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Eger KAB; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands.
Geelhoed JJM; Department of Pulmonology Leiden University Medical Center, Leiden, Netherlands.
van Glabbeek YLE; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Grotjohan HP; Department of Pulmonology, Isala Ziekenhuizen, Zwolle, Netherlands.
Hagens LA; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands.
Happe CM; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Hazes BD; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Heunks LMA; Department of Intensive Care, Amsterdam UMC, VUMC, Amsterdam, Netherlands.
van den Heuvel M; Department of Pulmonology, Radboud UMC, Nijmegen, Netherlands.
Hoefsloot W; Department of Pulmonology, Radboud UMC, Nijmegen, Netherlands.
Hoek RJA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Hoekstra R; Department of Pulmonology, Antonius Ziekenhuis, Sneek, Netherlands.
Hofstee HMA; Department of Internal Medicine, Haaglanden Medisch Centrum, The Hague, Netherlands.
Juffermans NP; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands; Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands.
Kemper EM; Hospital Pharmacy, Amsterdam UMC, AMC, Amsterdam, Netherlands.
Kos R; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands.
Kunst PWA; Department of Pulmonology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands.
Lammers A; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands.
van der Lee I; Department of Pulmonology, Spaarne Gasthuis, Haarlem, Netherlands.
van der Lee EL; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Maitland-van der Zee AH; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands.
Mau Asam PFM; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands.
Mieras A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Muller M; Department of Pulmonology, Catharina Ziekenhuis, Eindhoven, Netherlands.
Neefjes ECW; Department of Pulmonology, Catharina Ziekenhuis, Eindhoven, Netherlands.
Nossent EJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Oswald LMA; Department of Pulmonology, Sint Franciscus Ziekenhuis, Rotterdam, Netherlands.
Overbeek MJ; Department of Pulmonology, Haaglanden Medisch Centrum, The Hague, Netherlands.
Pamplona CC; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Paternotte N; Department of Pulmonology, Noordwest Ziekenhuisgroep, Alkmaar, Netherlands.
Pronk N; Department of Pulmonology, Gelre Ziekenhuis, Apeldoorn, Netherlands.
de Raaf MA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
van Raaij BFM; Department of Pulmonology Leiden University Medical Center, Leiden, Netherlands.
Reijrink M; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Schultz MJ; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands.
Serpa Neto A; Department of Critical Care Medicine and Institute of Education and Research, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Slob EMA; Department of Respiratory Medicine, Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, Netherlands.
Smeenk FWJM; Department of Pulmonology, Catharina Ziekenhuis, Eindhoven, Netherlands.
Smit MR; Department of Intensive Care, Amsterdam UMC, AMC, Amsterdam, Netherlands.
Smits AJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Stalenhoef JE; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands.
Tuinman PR; Department of Intensive Care, Amsterdam UMC, VUMC, Amsterdam, Netherlands.
Vanhove ALEM; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Wessels JN; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
van Wezenbeek JCC; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Vonk Noordegraaf A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
de Man FS; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Bogaard HJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VUMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Sep; Vol. 9 (9), pp. 957-968. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*therapy
Imatinib Mesylate/*administration & dosage
Protein Kinase Inhibitors/*administration & dosage
Respiration, Artificial/*statistics & numerical data
Respiratory Insufficiency/*therapy
Aged ; COVID-19/complications ; COVID-19/diagnosis ; COVID-19/virology ; Capillary Permeability/drug effects ; Combined Modality Therapy/adverse effects ; Combined Modality Therapy/methods ; Double-Blind Method ; Female ; Humans ; Imatinib Mesylate/adverse effects ; Male ; Middle Aged ; Netherlands ; Oxygen/administration & dosage ; Placebos/administration & dosage ; Placebos/adverse effects ; Protein Kinase Inhibitors/adverse effects ; Respiratory Insufficiency/diagnosis ; Respiratory Insufficiency/virology ; SARS-CoV-2/isolation & purification ; Severity of Illness Index ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Comparison of CHOP with THP-COP for peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective analysis using data from the population-based Osaka Cancer Registry.
Autorzy :
Kida S; Department of Hematology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka-shi, Osaka, 5418567, Japan.
Fuji S; Department of Hematology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka-shi, Osaka, 5418567, Japan. .
Morishima T; Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Nakata K; Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Miyashiro I; Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Ishikawa J; Department of Hematology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka-shi, Osaka, 5418567, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2021 Aug; Vol. 114 (2), pp. 246-251. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Doxorubicin/*analogs & derivatives
Lymphoma, T-Cell, Peripheral/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Combined Modality Therapy/adverse effects ; Combined Modality Therapy/methods ; Cyclophosphamide/adverse effects ; Cyclophosphamide/therapeutic use ; Disease Management ; Doxorubicin/adverse effects ; Doxorubicin/therapeutic use ; Female ; Health Care Surveys ; Hospitalization ; Humans ; Japan/epidemiology ; Lymphoma, T-Cell, Peripheral/diagnosis ; Lymphoma, T-Cell, Peripheral/epidemiology ; Male ; Middle Aged ; Prednisolone/adverse effects ; Prednisolone/therapeutic use ; Prednisone/adverse effects ; Prednisone/therapeutic use ; Prognosis ; Registries ; Retrospective Studies ; Treatment Outcome ; Vincristine/adverse effects ; Vincristine/therapeutic use
SCR Protocol :
CHOP protocol; VEP-THP protocol
Czasopismo naukowe
Tytuł :
Oligometastatic breast cancer: Are we there yet?
Autorzy :
AlSendi M; Medical Oncology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
O'Reilly D; Medical Oncology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
Zeidan YH; Department of Radiation Oncology, American University of Beirut, Beirut, Lebanon.
Kelly CM; Medical Oncology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1520-1528. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Breast Neoplasms/*pathology
Breast Neoplasms/*therapy
Combined Modality Therapy ; Female ; Humans ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł :
Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer.
Autorzy :
Darlix A; Department of Medical Oncology, University of Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.; Institut de Génomique Fonctionnelle, CNRS, INSERM, University of Montpellier, Montpellier, France.
Hirtz C; LBPC-PPC, University of Montpellier, CHU Montpellier, INSERM, Montpellier, France.
Mollevi C; Biometrics Unit, University of Montpellier, Institut regional du Cancer de Montpellier, Montpellier, France.; UA11 Institut Desbrest d'Epidémiologie et de Santé Publique, INSERM, University of Montpellier, Montpellier, France.
Ginestet N; LBPC-PPC, University of Montpellier, CHU Montpellier, INSERM, Montpellier, France.
Tiers L; LBPC-PPC, University of Montpellier, CHU Montpellier, INSERM, Montpellier, France.
Jacot W; Department of Medical Oncology, University of Montpellier, Institut régional du Cancer de Montpellier, Montpellier, France.
Lehmann S; LBPC-PPC, University of Montpellier, CHU Montpellier, INSERM, Montpellier, France.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2021 Oct 15; Vol. 149 (8), pp. 1605-1618. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*blood
Brain Neoplasms/*secondary
Breast Neoplasms/*pathology
Glial Fibrillary Acidic Protein/*blood
Adult ; Brain Neoplasms/blood ; Brain Neoplasms/therapy ; Breast Neoplasms/blood ; Breast Neoplasms/therapy ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Prognosis ; ROC Curve ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Eosinophilic Esophagitis: A Review.
Autorzy :
Muir A; Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Falk GW; Division of Gastroenterology, Hospital of the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Pokaż więcej
Źródło :
JAMA [JAMA] 2021 Oct 05; Vol. 326 (13), pp. 1310-1318.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Eosinophilic Esophagitis*/diagnosis
Eosinophilic Esophagitis*/etiology
Eosinophilic Esophagitis*/pathology
Eosinophilic Esophagitis*/therapy
Adrenal Cortex Hormones/therapeutic use ; Adult ; Amino Acids/therapeutic use ; Budesonide/therapeutic use ; Capsules/administration & dosage ; Combined Modality Therapy/methods ; Deglutition Disorders/etiology ; Dilatation ; Eosinophils/pathology ; Esophagoscopy ; Esophagus/pathology ; Fluticasone/therapeutic use ; Food Hypersensitivity/diagnosis ; Food Hypersensitivity/diet therapy ; Gene-Environment Interaction ; Humans ; Proton Pump Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł :
The effect of magnetic therapy and moderate aerobic exercise on osteoporotic patients: A randomized clinical study.
Autorzy :
Eid MM; Department of Physical Therapy, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.; Department of Physical Therapy for Surgery, Faculty of Physical Therapy, Cairo University, Giza, Egypt.
El-Gendy AM; Department of Physical Therapy, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.; Department of Basic Sciences, Faculty of Physical Therapy, Cairo University, Giza, Egypt.
Abdelbasset WK; Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.; Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt.
Elkholi SM; Department of Rehabilitation Sciences, Faculty of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Abdel-Fattah MS; Department of Physical Therapy for Cardiovascular/Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University, Giza, Egypt.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Oct 01; Vol. 100 (39), pp. e27379.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Exercise*
Magnetic Field Therapy/*methods
Osteoporosis/*therapy
Absorptiometry, Photon ; Adult ; Analysis of Variance ; Bone Density ; Combined Modality Therapy/methods ; Female ; Hip Joint/diagnostic imaging ; Humans ; Middle Aged
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies